These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16706365)

  • 41. [Evaluation of brain-targeted trendence of scutellarin nasal administration].
    Shi S; Wu J; Dai W; Li C; Ge W
    Zhongguo Zhong Yao Za Zhi; 2010 Sep; 35(18):2453-6. PubMed ID: 21141499
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and Evaluation of PEG-PR for Water Flux Correction in an In Situ Rat Perfusion Model.
    Chen G; Min X; Zhang Q; Zhang Z; Wen M; Yang J; Zou M; Sun W; Cheng G
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33158074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanisms of polyethylene glycol 400 permeability of perfused rat intestine.
    Krugliak P; Hollander D; Ma TY; Tran D; Dadufalza VD; Katz KD; Le K
    Gastroenterology; 1989 Nov; 97(5):1164-70. PubMed ID: 2792655
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Absorption of polyethylene glycol oligomers (330-1 122 Da) is greater in the jejunum than in the ileum of rats.
    Kim M
    J Nutr; 1996 Sep; 126(9):2172-8. PubMed ID: 8814205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determination of aglycone conjugated metabolites of scutellarin in rat plasma by HPLC.
    Huang J; Li N; Yu Y; Weng W; Huang X
    J Pharm Biomed Anal; 2006 Feb; 40(2):465-71. PubMed ID: 16181763
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel polyrotaxane-based delivery system for scutellarin: preparation, characterization, and in vitro evaluation.
    Jiang RJ; Yang B; Liu ZK; Zhao YL; Liao XL; Yang J; Gao CZ; Wang F; Han B
    Carbohydr Res; 2013 Oct; 380():149-55. PubMed ID: 24036381
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetic interaction between scutellarin and valsartan in rats.
    Cui MY; Tian CC; Ju AX; Zhang CT; Li QH
    Yao Xue Xue Bao; 2013 Apr; 48(4):541-6. PubMed ID: 23833943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improved pharmacokinetic properties of a polyethylene glycol-modified form of interferon-beta-1a with preserved in vitro bioactivity.
    Pepinsky RB; LePage DJ; Gill A; Chakraborty A; Vaidyanathan S; Green M; Baker DP; Whalley E; Hochman PS; Martin P
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1059-66. PubMed ID: 11356929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Controlled Release, Intestinal Transport, and Oral Bioavailablity of Paclitaxel Can be Considerably Increased Using Suitably Tailored Pegylated Poly(Anhydride) Nanoparticles.
    Calleja P; Espuelas S; Vauthier C; Ponchel G; Irache JM
    J Pharm Sci; 2015 Sep; 104(9):2877-86. PubMed ID: 25600579
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis, characterization and cytotoxicity of poly(ethylene glycol)-graft-trimethyl chitosan block copolymers.
    Mao S; Shuai X; Unger F; Wittmar M; Xie X; Kissel T
    Biomaterials; 2005 Nov; 26(32):6343-56. PubMed ID: 15913769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Absorption of polyethylene glycols 600 through 2000: the molecular weight dependence of gastrointestinal and nasal absorption.
    Donovan MD; Flynn GL; Amidon GL
    Pharm Res; 1990 Aug; 7(8):863-8. PubMed ID: 2235883
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polyethylene glycol-drug ester conjugates for prolonged retention of small inhaled drugs in the lung.
    Bayard FJ; Thielemans W; Pritchard DI; Paine SW; Young SS; Bäckman P; Ewing P; Bosquillon C
    J Control Release; 2013 Oct; 171(2):234-40. PubMed ID: 23916883
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of human efflux transporter ABCC2 (MRP2) by self-emulsifying drug delivery system: influences of concentration and combination of excipients.
    Li L; Yi T; Lam CW
    J Pharm Pharm Sci; 2014; 17(4):447-60. PubMed ID: 25579428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preparation, characterization and evaluation of breviscapine lipid emulsions coated with monooleate-PEG-COOH.
    Xiong F; Xiong C; Yao J; Chen X; Gu N
    Int J Pharm; 2011 Dec; 421(2):275-82. PubMed ID: 22001842
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties.
    Däpp S; García Garayoa E; Maes V; Brans L; Tourwé DA; Müller C; Schibli R
    Nucl Med Biol; 2011 Oct; 38(7):997-1009. PubMed ID: 21982571
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validation of an HPLC method for the determination of scutellarin in rat plasma and its pharmacokinetics.
    Hao X; Cheng G; Sun J; Zou M; Yu J; Zhang S; Cui F
    J Pharm Biomed Anal; 2005 Jun; 38(2):360-3. PubMed ID: 15925232
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of bile on the oral absorption of halofantrine in polyethylene glycol 400 and polysorbate 80 formulations dosed to bile duct cannulated rats.
    Tønsberg H; Holm R; Mu H; Boll JB; Jacobsen J; Müllertz A
    J Pharm Pharmacol; 2011 Jun; 63(6):817-24. PubMed ID: 21585380
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis, characterization and in vitro studies of pegylated melphalan conjugates.
    Ajazuddin ; Alexander A; Amarji B; Kanaujia P
    Drug Dev Ind Pharm; 2013 Jul; 39(7):1053-62. PubMed ID: 22779444
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Intestinal lymphatic transport of breviscapine orally administered in rat].
    Gong YJ; Wang JX; Zhang Y; Shen M; Fu CM; Shen T
    Yao Xue Xue Bao; 2011 Oct; 46(10):1262-7. PubMed ID: 22242462
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Advances in studies on pharmacokinetics of scutellarin and scutellarein].
    Liu J; Xiong Y
    Zhongguo Zhong Yao Za Zhi; 2009 Dec; 34(24):3165-8. PubMed ID: 20352990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.